Coya Therapeutics COYA Insider Ownership

NASDAQ COYA
$4.21 +0.01 (+0.24%)
At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

81.07K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.252%
■0% pp QoQ
Shares Held by Insiders
59.07K
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
23.46Mn
23,457,849 shares
Direct Holdings
59.07K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Updated

Over the trailing 12 months, COYA insiders made no open-market trades in the stock.

Form 4 Holdings

Insiders Holding COYA

Insiders 8
Shares held 81.07K
Of outstanding 0.346%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Dov A Md Goldstein Director 27,557 0 27,557 34.0% 19 Aug, 2025
2 Adrian Hepner Chief Medical Officer 10,000 0 10,000 12.3% 04 Jan, 2023
3 Arun Swaminathan Chief Executive Officer 10,000 0 10,000 12.3% 13 Nov, 2024
4 Anabella Villalobos Director 10,000 0 10,000 12.3% 04 Jan, 2023
5 Howard Berman Chief Executive Officer 10,000 0 10,000 12.3% 04 Jan, 2023
6 David S Snyder Chief Financial Officer 8,800 0 8,800 10.9% 14 Nov, 2024
7 Fred Grossman Chief Medical Officer 2,710 0 2,710 3.3% 12 Nov, 2024
8 Hideki Garren Director 2,000 0 2,000 2.5% 04 Jan, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

60 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
09 Apr, 2026 Mark H Pavao Director Acquired A 10,000 $0.00 $0 10,000 Direct
22 Jan, 2026 David S Snyder Chief Financial Officer Acquired A 140,041 $0.00 $0 140,041 Direct
22 Jan, 2026 Howard Berman Executive Chairman Acquired A 15,257 $0.00 $0 15,257 Direct
22 Jan, 2026 Fred Grossman Chief Medical Officer Acquired A 140,041 $0.00 $0 140,041 Direct
22 Jan, 2026 Arun Swaminathan Chief Executive Officer Acquired A 293,983 $0.00 $0 293,983 Direct
02 Jan, 2026 Anabella Villalobos Director Acquired A 10,000 $0.00 $0 10,000 Direct
02 Jan, 2026 Dov A Md Goldstein Director Acquired A 10,000 $0.00 $0 10,000 Direct
02 Jan, 2026 Dieter Weinand Director Acquired A 10,000 $0.00 $0 10,000 Direct
02 Jan, 2026 Ann Lee Director Acquired A 10,000 $0.00 $0 10,000 Direct
02 Jan, 2026 Wilbur L Jr Ross Director Acquired A 10,000 $0.00 $0 10,000 Direct
18 Aug, 2025 Dov A Md Goldstein Director Acquired M 17,557 $1.09 $19.14K 27,557 Direct
18 Aug, 2025 Dov A Md Goldstein Director Disposed M 17,557 $0.00 $0 0 Direct
25 Feb, 2025 Wilbur L Jr Ross Director Acquired A 5,000 $0.00 $0 5,000 Direct
25 Feb, 2025 Ann Lee Director Acquired A 5,000 $0.00 $0 5,000 Direct
25 Feb, 2025 Dieter Weinand Director Acquired A 5,000 $0.00 $0 5,000 Direct
25 Feb, 2025 Dov A Md Goldstein Director Acquired A 5,000 $0.00 $0 5,000 Direct
25 Feb, 2025 Anabella Villalobos Director Acquired A 5,000 $0.00 $0 5,000 Direct
09 Jan, 2025 Fred Grossman Chief Medical Officer Acquired A 140,562 $0.00 $0 140,562 Direct
09 Jan, 2025 Arun Swaminathan Chief Executive Officer Acquired A 240,964 $0.00 $0 240,964 Direct
09 Jan, 2025 David S Snyder Chief Financial Officer Acquired A 140,562 $0.00 $0 140,562 Direct